Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,199.0
25.2 (0.79%)

 

  • STI Straits Times Index
    3,199.0
    25.2 (0.79%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,606.0
    7.7 (0.48%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,787.2
    377.5 (1.49%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,593.2
    25.0 (0.70%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,215.5
    190.1 (0.65%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,656.0
    -2.8 (-0.04%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,613.6M
  • Value: 1,230.2M
  • Rise: 192
  • Fall: 154
  • Unch: 405

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.081-0.001
Hatten Land0.073-0.005
Jiutian Chemical0.089-0.002
Shen Yao0.003-0.001
Rex Intl0.350+0.025
AusGroup0.029+0.003
Singtel2.550-
Sinjia Land0.052+0.005
Oceanus0.040-
Leader Env0.083+0.009

World Indices

World Indices
Name Last Change
Nasdaq 15,021.8 +124.5
HSI 25,787.2 +377.5
HSCEI 9,136.1 +164.7
Jakarta 6,656.0 -2.8
Nikkei 225 29,215.5 +190.1
SSE Comp 3,593.2 +25.0
Shanghai A 3,765.7 +26.2
Shanghai B 280.0 +0.7
KOSPI 3,029.0 +22.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ANNOVIS BIO INC ANNOVIS BIO
Updated on 18 Oct 2021 (End of trading day)
Last (USD): 29.200 Change: +1.210 High: 30.270 Remarks: -
Change (%): +4.32 Low: 28.380
Open 28.660 Yesterday's Close 27.99
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 189,107 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.67428 Trailing EPS (USD) e -1.04131 NAV (USD) b 6.0011
PE a - Trailing PE f - Price / NAV b 4.8658
Dividend (USD) d - Cash In Hand (USD) g 6.0766 Issued & Paid-up Shares c 8,100,570
Dividend Yield (%) d - Price / Cash In Hand g 4.805 Treasury Shares h -
Market Cap (M) 236.537 Enterprise Value (M) 187.313
Piotroski F Score 2 Exchange Code ANVS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 189.58 Free Float (%) 68.1
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 29 Jul 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 27 Jan 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ANNOVIS BIO INC NYSE American 236.537 - - 4.8658 -
Industry Pharmaceuticals: Major NYSE American 328.072 - - 13.9645 -
Local Peer BROOKLYN IMMUNO THERAPEUTICS INC NYSE American 1,075.819 - - 30.5793 -
Local Peer CYBIN INC NYSE American 309.766 - - 5.0298 -
Local Peer NAVIDEA BIOPHARMACEUTICALS INC NYSE American 285.484 - - 50.0000 -
Local Peer AGEX THERAPEUTICS INC NYSE American 34.883 - - -4.2276 -
Local Peer TIMBER PHARMACEUTICALS INC NYSE American 25.944 - - -13.7953 -
Global Peer JOHNSON & JOHNSON NYSE 421,512.698 28.647 23.724 6.0580 2.486
Global Peer PFIZER INC NYSE 231,668.431 24.092 17.513 3.3076 3.677
Global Peer ELI LILLY AND COMPANY NYSE 228,603.727 36.909 37.657 35.4733 1.239
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 200,450.143 24.685 22.287 3.7092 2.341
Global Peer MERCK & CO INC NYSE 195,295.196 27.635 35.056 5.8658 3.213
Global Peer ABBVIE INC NYSE 189,848.147 41.670 28.813 15.1044 4.500
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 183,696.428 57.477 48.713 11.7183 1.958
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 183,335.881 28.451 25.753 17.5356 1.301
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 126,526.943 - - 3.4375 3.263
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 121,368.928 8.646 17.526 1.6184 2.784
Other Global Peers GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 (NYSE), WUXI APPTEC CO LTD (HKEx), TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), ROYALTY PHARMA PLC (NASDAQ), VIATRIS INC (NASDAQ), HANSOH PHARMACEUTICAL GROUP CO LTD (HKEx), REPLIGEN CORP (NASDAQ), INNOVENT BIOLOGICS INC (HKEx), CANSINO BIOLOGICS INC (HKEx), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ORGANON & CO (NYSE), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), SINOPHARM GROUP CO. LTD. (HKEx), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), CUREVAC NV (NASDAQ), REMEGEN CO LTD (HKEx), ALLAKOS INC (NASDAQ), SHANGHAI PHARMACEUTICALS HOLDING CO (HKEx), HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS (NASDAQ), HUTCHMED (CHINA) LIMITED (HKEx), HYGEIA HEALTHCARE HLDGS CO LTD (HKEx), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), SHANGHAI JUNSHI BIOSCIENCES CO LTD (HKEx), AKESO INC (HKEx), CHINA MEDICAL SYSTEM HLDGS LTD (HKEx), GUANGZHOU BAIYUNSHAN PHARMACEUTICAL (HKEx), INNOCARE PHARMA LTD (HKEx), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), CHINA RESOURCES PHARMACEUTICAL GR (HKEx), APELLIS PHARMACEUTICALS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), CHINA GRAND PHARMACEUTICAL & HEALTH (HKEx), CARSGEN THERAPEUTICS HLDGS LTD (HKEx), EMERGENT BIOSOLUTIONS INC (NYSE), SIMCERE PHARMACEUTICAL GRP LTD (HKEx), OPKO HEALTH INC (NASDAQ), CHINA TRADITIONAL CHINESE MED HLDGS (HKEx), TURNING POINT THERAPEUTICS INC (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), ERASCA INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), ADC THERAPEUTICS SA (NYSE), IGM BIOSCIENCES INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), SHANGHAI HENLIUS BIOTECH INC (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), EVEREST MEDICINES LTD (HKEx), DICERNA PHARMACEUTICALS INC. (NASDAQ), SHENZHEN HEPALINK PHARMACEUTICAL (HKEx), SSY GROUP LIMITED (HKEx), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CSTONE PHARMACEUTICALS (HKEx), OCUMENSION THERAPEUTICS (HKEx), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), UNITED LABORATORIES INTL HLDGS LTD (HKEx), ZYMEWORKS INC (NYSE), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), PROCAPS GROUP S A (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), Kimia Farma Tbk. (IDX), ABBISKO CAYMAN LTD (HKEx), GOSSAMER BIO INC (NASDAQ), BEIJING TONG REN TANG CHINESE MEDIC (HKEx), IMMUNOTECH BIOPHARM LTD (HKEx), FULCRUM THERAPEUTICS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), ICOSAVAX INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), KRONOS BIO INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), CK LIFE SCIENCES INTL HLDG (HKEx), SCICLONE PHARMACEUTICALS (HLDGS) LT (HKEx), PRAXIS PRECISION MEDICINES INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), ANTENGENE CORP LTD (HKEx), FORMA THERAPEUTICS HLDGS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), ANNEXON INC (NASDAQ), GH RESEARCH PLC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), PETIQ INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), TRANSCENTA HOLDING LTD (HKEx), POINT BIOPHARMA GLOBAL INC (NASDAQ), CHINA SHINEWAY PHARMACEUTICAL GR (HKEx), VERU INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), HUA MEDICINE (HKEx), SIGA TECHNOLOGIES INC (NASDAQ), PHARVARIS NV (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), ZHAOKE OPHTHALMOLOGY LTD (HKEx), Soho Global Health Tbk. (IDX), WEREWOLF THERAPEUTICS INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), AC IMMUNE SA (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), IGBB (Bursa), EVELO BIOSCIENCES INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), EVOLUS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), MINK THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), PYXIS ONCOLOGY INC (NASDAQ), CLENE INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), 89BIO INC (NASDAQ), ESSA PHARMA INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), RACE ONCOLOGY LTD (ASX), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), BIOMEA FUSION INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), TOT BIOPHARM INTL CO LTD (HKEx), DAWNRAYS PHARMACEUTICAL HLDGS (HKEx), FUSION PHARMACEUTICALS INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), ATHENEX INC (NASDAQ), XOMA CORP (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), NEXIMMUNE INC (NASDAQ), BSTEAD (Bursa), CHECKPOINT THERAPEUTICS INC (NASDAQ), FUSEN PHARMACEUTICAL CO LTD (HKEx), DURECT CORP (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), HARROW HEALTH INC (NASDAQ), VINCERX PHARMA INC (NASDAQ), PHARMA (Bursa), ANGION BIOMEDICA CORP (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), TRICIDA INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), OBSEVA SA (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), IMMUNIC INC (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), INOZYME PHARMA INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), ALZAMEND NEURO INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), IP (SET), 180 LIFE SCIENCES CORP (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), CHINA BIOTECH SERVICES HLDGS LTD (HKEx), AQUESTIVE THERAPEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), NOVAN INC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), POLYPID LTD (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), EYENOVIA INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), IX Biopharma (SGX), ENTERA BIO LTD (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), ZHONGZHI PHARMACEUTICAL HLDGS LTD (HKEx), VTV THERAPEUTICS INC (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), CLARUS THERAPEUTICS HLDGS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), Merck Tbk. (IDX), ODONATE THERAPEUTICS INC (NASDAQ), NOXOPHARM LTD (ASX), GENPREX INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), LANNETT CO INC (NYSE), KOTRA (Bursa), EDESA BIOTECH INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), CRESO PHARMA LTD (ASX), IMARA INC (NASDAQ), CHARMACY PHARMACEUTICAL CO LTD (HKEx), MEDIWOUND LTD (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), NEW RAY MEDICINE INTL HLDG LTD (HKEx), YUMANITY THERAPEUTICS INC (NASDAQ), GALECTO INC (NASDAQ), PROPHASE LABS INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), GRAYBUG VISION INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), Phapros Tbk. (IDX), OCUPHIRE PHARMA INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), NEW CENTURY HEALTHCARE HLDGS CO LTD (HKEx), SANAI HEALTH INDUSTRY GP CO LTD (HKEx), PAK FAH YEOW INTERNATIONAL (HKEx), NOVA (Bursa), MANNATECH INC (NASDAQ), Hyphens Pharma (SGX), ABVC BIOPHARMA INC (NASDAQ), BONE BIOLOGICS CORP (NASDAQ), EXOPHARM LTD (ASX), VYNE THERAPEUTICS INC (NASDAQ), INVION LTD (ASX), BIOHLDG (Bursa), MODERN CHINESE MEDICINE GRP CO LTD (HKEx), VIRPAX PHARMA INC (NASDAQ), WAI YUEN TONG MEDICINE HOLDINGS LTD (HKEx), SHENZHEN NEPTUNUS INTERLONG BIO-TEC (HKEx), UNIVERSE PHARMACEUTICALS INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), RENOVORX INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), BAUDAX BIO INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), PURAPHARM CORPORATION LIMITED (HKEx), SEQLL INC (NASDAQ), PHARMAXIS (ASX), CNS PHARMACEUTICALS INC (NASDAQ), MEDLAB CLINICAL LIMITED (ASX), VIRIOS THERAPEUTICS INC (NASDAQ), PASITHEA THERAPEUTICS CORP (NASDAQ), XORTX THERAPEUTICS INC (NASDAQ), DERMATA THERAPEUTICS INC (NASDAQ), PALLA PHARMA LTD (ASX), ACER THERAPEUTICS INC (NASDAQ), JCT (SET), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), EXTRAWELL PHARMACEUTICAL HLDGS (HKEx), SUNZEN (Bursa), NLS PHARMACEUTICS LTD (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), PAINREFORM LTD (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), ACRUX (ASX), IMMURON LIMITED (ASX), AVENUE THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), NANJING SINOLIFE UNITED COMPANY LTD (HKEx), TALI DIGITAL LIMITED (ASX), ISLAND PHARMACEUTICALS LTD (ASX), TITAN PHARMACEUTICAL INC (NASDAQ), SUDA PHARMACEUTICALS LTD (ASX), PETROS PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), PA SHUN INTERNATIONAL HOLDINGS LTD (HKEx), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+2.070
+7.63 %
10 Days -+2.850
+10.82 %
20 Days --3.960
-11.94 %
Medium Term Return 3 Months --71.980
-71.14 %
6 Months -+6.860
+30.71 %
1 Year -+24.220
+486.35 %
Annualised Return Annualised --
+486.35 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 4.140 - 132.000 Change From 1 Year Low +25.060 % Change From 1 Year Low (%) +605.31
Change From 1 Year High -102.800 % Change From 1 Year High (%) -77.88
2 Years Range 2.418 - 132.000 Change From 2 Years Low +26.782 % Change From 2 Years Low (%) +1107.61
Change From 2 Years High -102.800 % Change From 2 Years High (%) -77.88
5 Years Range 2.418 - 132.000 Change From 5 Years Low +26.782 % Change From 5 Years Low (%) +1107.61
Change From 5 Years High -102.800 % Change From 5 Years High (%) -77.88
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Annovis Bio, Inc. is a clinical stage drug platform company, which develops drugs to treat neurodegeneration. The firm compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chronic neurodegenerative disorders. It is also develops ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.

Historical Price Data

Date Open High Low Close Volume VWAP
18 Oct 2021 28.660 30.270 28.380 29.200 189,107 -
15 Oct 2021 31.290 31.290 27.500 27.990 375,712 -
14 Oct 2021 30.600 32.830 29.800 30.810 530,900 -
13 Oct 2021 27.550 28.210 26.910 27.500 122,214 -
12 Oct 2021 27.270 27.940 26.750 27.130 76,027 -
11 Oct 2021 26.470 28.150 26.380 26.960 157,004 -
08 Oct 2021 26.710 27.700 26.340 26.570 108,001 -
07 Oct 2021 25.580 27.710 24.520 26.770 206,798 -
06 Oct 2021 25.160 26.710 24.470 25.670 255,125 -
05 Oct 2021 31.470 33.090 25.317 26.350 1,672,064 -
04 Oct 2021 31.680 32.220 30.350 30.350 146,109 -
01 Oct 2021 31.450 31.800 29.500 31.740 140,359 -
30 Sep 2021 31.070 32.020 30.760 31.750 112,449 -
29 Sep 2021 35.000 35.550 31.160 31.340 195,651 -
28 Sep 2021 35.800 36.630 34.680 35.140 122,258 -
27 Sep 2021 34.070 36.690 33.600 36.460 146,327 -
24 Sep 2021 34.520 36.062 33.370 34.490 176,708 -
23 Sep 2021 32.620 35.550 32.220 35.430 213,780 -
22 Sep 2021 34.000 34.470 32.150 32.680 191,304 -
21 Sep 2021 31.350 34.000 30.950 33.160 220,712 -
20 Sep 2021 31.550 33.000 30.340 30.950 220,360 -
17 Sep 2021 31.510 33.500 30.800 33.500 202,334 -
Summary
Current 2 Weeks
(05 Oct 2021 to 18 Oct 2021)
31.470 33.090 24.470 29.200 3,692,952 -
Previous 2 Weeks
(21 Sep 2021 to 04 Oct 2021)
31.350 34.000 24.470 30.350 1,665,657 -
4 Weeks from
(23 Aug 2021 to 20 Sep 2021)
37.190 40.200 24.470 30.950 5,332,351 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.